Clinical Trial Update: Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results update evaluating estradiol for ER beta–positive, triple-negative breast cancer in locally advanced or metastatic disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• ESTRADIOL (Estradiol)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Triple-Negative Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-05